OverviewSuggest Edit

Admetsys is a biomedical technology company that develops a pancreas system for use in hospital and surgical care. Its technology and supplementary remote monitoring products provide hospitals with the automation of insulin and glucose monitoring and treatment. The company helps people at diabetic risk to correct abnormal glucose levels, prevent infection, and reduce complications.

Latest Updates

Employees (est.) (Sept 2021)6
Cybersecurity ratingBMore

Admetsys Financials and Metrics

Summary Metrics

Founding Date


Admetsys total Funding

$35 k

Admetsys latest funding size

$35 k

Time since last funding

3 years ago

Admetsys investors

Admetsys's latest funding round in May 2018 was reported to be $35 k. In total, Admetsys has raised $35 k
Show all financial metrics

Admetsys Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Admetsys Online and Social Media Presence

Embed Graph

Admetsys News and Updates

Artificial Pancreas Device System Market Future Prospects 2027 with Leading Key Insights – TypeZero Technologies, Admetsys, Beta Bionics, Cellnovo

artificial pancreas device systems market accounted to US$ 481.8 Mn in 2017 and is expected to grow at a CAGR of 20.9% during the forecast period 2018 - 2025, to account to US$ 2,168.1Mn by 2025. Posted via Industry Today. Follow us on Twitter @IndustryToday

Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System

BOSTON, Oct. 13, 2020 /PRNewswire/ -- Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that it received European regulatory approval (CE Mark) for its flagship PrecisionOne™ automated glycemic control and continuous...

Admetsys Frequently Asked Questions

  • When was Admetsys founded?

    Admetsys was founded in 2010.

  • How many employees does Admetsys have?

    Admetsys has 6 employees.

  • Who are Admetsys competitors?

    Competitors of Admetsys include Medtrum, DiaMonTech and Active Healthcare.